JAZZ Overview
Upcoming Projects (JAZZ)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (JAZZ)
-
Reviewing the recent data presented on Epidiolex at the European Epilepsy Congress 2024.
Ticker: JAZZ
Executed On: Oct 02, 2024 at 11:30 AM EDT -
A Second Look: Reviewing the recent data presented on Epidiolex at the European Epilepsy Congress 2024.
Ticker: JAZZ
Executed On: Sep 27, 2024 at 01:30 PM EDT -
Second View: Discussing new data from Phase II trial on Zanidatamab + chemotherapy for first-line (1L) treatment of HER2+ advanced metastatic gastro-oesophageal adenocarcinoma (mGEA)
Ticker: JAZZ
Executed On: Sep 18, 2024 at 12:00 PM EDT -
Discussing new data from Phase II trial on Zanidatamab + chemotherapy for first-line (1L) treatment of HER2+ advanced metastatic gastro-oesophageal adenocarcinoma (mGEA)
Ticker: JAZZ
Executed On: Sep 12, 2024 at 09:00 AM EDT -
A Third Opinion: Discussing the recent data from Takeda's phase 2b trial of TAK-861 as a treatment for patients with narcolepsy.
Tickers: TAK, JAZZ
Executed On: Aug 01, 2024 at 03:00 PM EDT -
A Second Opinion: Discussing the recent data from Takeda's phase 2b trial of TAK-861 as a treatment for patients with narcolepsy.
Tickers: TAK, JAZZ
Executed On: Jul 26, 2024 at 12:00 PM EDT -
Discussing the recent data from Takeda's phase 2b trial of TAK-861 as a treatment for patients with narcolepsy.
Tickers: TAK, JAZZ
Executed On: Jun 17, 2024 at 04:00 PM EDT -
A Third Look: Investigating the recent post-approval data on LUMRYZ and Xywav in patients with narcolepsy presented at World Sleep 2023.
Tickers: AVDL, JAZZ
Executed On: Jan 04, 2024 at 04:30 PM EST -
A Second Look: Investigating the recent post-approval data on LUMRYZ and Xywav in patients with narcolepsy presented at World Sleep 2023.
Tickers: AVDL, JAZZ
Executed On: Dec 21, 2023 at 05:15 PM EST -
Investigating the recent post-approval data on LUMRYZ and Xywav in patients with narcolepsy presented at World Sleep 2023.
Tickers: AVDL, JAZZ
Executed On: Nov 03, 2023 at 01:00 PM EDT -
A second look: Discussion of therapeutic options in NT1 (Narcolepsy Type 1) and Orexin agonists
Tickers: JAZZ, TAK, AVDL, HRMY
Executed On: Aug 10, 2023 at 01:30 PM EDT -
Discussion of therapeutic options in NT1 (Narcolepsy Type 1) and Orexin agonists
Tickers: TAK, JAZZ, AVDL, HRMY
Executed On: Aug 09, 2023 at 05:30 PM EDT -
Discussing the use of Epidiolex in treating Dravet Syndrome and LGS with a prescriber
Ticker: JAZZ
Executed On: Jun 23, 2022 at 11:30 AM EDT -
Discussing the use of Epidiolex in treating Dravet syndrome and LGS with a prescriber
Ticker: JAZZ
Executed On: Jun 21, 2022 at 03:45 PM EDT -
Discussing the use of Epidiolex in treating Dravet syndrome with a prescriber
Ticker: JAZZ
Executed On: Jun 17, 2022 at 11:30 AM EDT -
Checking on use of Epidiolex and Fintepla in the real world
Tickers: JAZZ, UCB
Executed On: May 10, 2022 at 11:00 AM EDT -
A Second View: Discussing the potential of FT218 and Xyrem/Xywav in treating patients with Narcolepsy
Tickers: JAZZ, AVDL
Executed On: Mar 29, 2022 at 01:30 PM EDT -
Discussing the potential of FT218 and Xyrem/Xywav in treating patients with Narcolepsy
Tickers: JAZZ, AVDL
Executed On: Mar 29, 2022 at 10:00 AM EDT
Upcoming & Overdue Catalysts (JAZZ)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (JAZZ)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
